Welcome to the new version of CaltechAUTHORS. Login is currently restricted to library staff. If you notice any issues, please email coda@library.caltech.edu
Published March 16, 1999 | Published
Journal Article Open

A cloning method to identify caspases and their regulators in yeast: Identification of Drosophila IAP1 as an inhibitor of the Drosophila caspase DCP-1

Abstract

Site-specific proteases play critical roles in regulating many cellular processes. To identify novel site-specific proteases, their regulators, and substrates, we have designed a general reporter system in Saccharomyces cerevisiae in which a transcription factor is linked to the intracellular domain of a transmembrane protein by protease cleavage sites. Here, we explore the efficacy of this approach by using caspases, a family of aspartate-specific cysteine proteases, as a model. Introduction of an active caspase into cells that express a caspase-cleavable reporter results in the release of the transcription factor from the membrane and subsequent activation of a nuclear reporter. We show that known caspases activate the reporter, that an activator of caspase activity stimulates reporter activation in the presence of an otherwise inactive caspase, and that caspase inhibitors suppress caspase-dependent reporter activity. We also find that, although low or moderate levels of active caspase expression do not compromise yeast cell growth, higher level expression leads to lethality. We have exploited this observation to isolate clones from a Drosophila embryo cDNA library that block DCP-1 caspase-dependent yeast cell death. Among these clones, we identified the known cell death inhibitor DIAP1. We showed, by using bacterially synthesized proteins, that glutathione S-transferase–DIAP1 directly inhibits DCP-1 caspase activity but that it had minimal effect on the activity of a predomainless version of a second Drosophila caspase, drICE.

Additional Information

© 1999 National Academy of Sciences. Communicated by Alexander Varshavsky, California Institute of Technology, Pasadena, CA, January 12, 1999 (received for review November 18, 1998). We thank the following for providing plasmids and strains: J. Adams (CD4), J. Yuan (pbactced38Z), L. K. Miller (pBS p35), H. Steller (DCP-1), D. Vaux (MIHA and caspases 3 and 9), X. Wang (Apaf-1), and R. Deshaies (yeast strains and plasmids). R. Deshaies, P. Sternberg, M. Guo, and W. Y. Shou provided helpful discussions and comments. C.J.H. is supported by a fellowship from the Human Frontiers Science Program. B.A.H. is a Searle Scholar. This work was supported by National Institutes of Health Grant GM057422-01 and a Burroughs Wellcome Fund New Investigator Award in the Pharmacological Sciences to B.A.H. C.J.H. and S.L.W. contributed equally to this work. The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked ''advertisement'' in accordance with 18 U.S.C. §1734 solely to indicate this fact.

Attached Files

Published - PNAS-1999-Hawkins-2885-90.pdf

Files

PNAS-1999-Hawkins-2885-90.pdf
Files (643.9 kB)
Name Size Download all
md5:613194a4af65c29254a24a0e8b1c005a
643.9 kB Preview Download

Additional details

Created:
August 19, 2023
Modified:
October 18, 2023